These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30994482)

  • 1. Contemporary Management of Polycystic Ovarian Syndrome.
    Zimmerman LD; Setton R; Pereira N; Rosenwaks Z
    Clin Obstet Gynecol; 2019 Jun; 62(2):271-281. PubMed ID: 30994482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Advance in treatment of polycystic ovary syndrome].
    Krysiak R; Okopień B; Herman ZS
    Pol Merkur Lekarski; 2005 Dec; 19(114):848-54. PubMed ID: 16521439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian stimulation in polycystic ovarian syndrome.
    Or Y; Shoham Z
    Int Surg; 2006; 91(5 Suppl):S25-30. PubMed ID: 17436602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The treatment of polycystic ovary syndrome.
    Ajossa S; Guerriero S; Paoletti AM; Orrù M; Melis GB
    Minerva Ginecol; 2004 Feb; 56(1):15-26. PubMed ID: 14973407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term treatment with the combination ethinylestradiol and cyproterone acetate in polycystic ovary syndrome.
    Falsetti L; Galbignani E
    Contraception; 1990 Dec; 42(6):611-9. PubMed ID: 2150631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of metformin on the plasminogen activator system, endocrine, metabolic profiles in patients with polycystic ovary syndrome and clomiphene resistant cases].
    Song J; Shen H; Li J; Huang Z; Zhang Y
    Zhonghua Fu Chan Ke Za Zhi; 2002 Feb; 37(2):86-9. PubMed ID: 11953071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controversial association between polycystic ovary syndrome and breast cancer.
    Carvalho MJ; Subtil S; Rodrigues Â; Oliveira J; Figueiredo-Dias M
    Eur J Obstet Gynecol Reprod Biol; 2019 Dec; 243():125-132. PubMed ID: 31693949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of oral contraceptive and metformin did not improve insulin resistance in women with polycystic ovary syndrome.
    Iwata MC; Porquere L; Sorpreso IC; Baracat EC; Soares Júnior JM
    Rev Assoc Med Bras (1992); 2015; 61(3):215-9. PubMed ID: 26248242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polycystic ovary syndrome.
    Pfeifer SM
    J Pediatr Adolesc Gynecol; 2003 Aug; 16(4):259-63. PubMed ID: 14550391
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of the efficiency of clomiphene citrate and letrozole in combination with metformin in moderately obese clomiphene citrate-resistant polycystic ovarian syndrome patients.
    Bjelica A; Trninić-Pjević A; Mladenović-Segedi L; Cetković N; Petrović D
    Srp Arh Celok Lek; 2016; 144(3-4):146-50. PubMed ID: 27483558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and Treatment of Polycystic Ovary Syndrome.
    Williams T; Mortada R; Porter S
    Am Fam Physician; 2016 Jul; 94(2):106-13. PubMed ID: 27419327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clomiphene citrate alternatives for the initial management of polycystic ovary syndrome: an evidence-based approach.
    Abu Hashim H
    Arch Gynecol Obstet; 2012 Jun; 285(6):1737-45. PubMed ID: 22392485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction of insulin resistance and hyperandrogenism in polycystic ovary syndrome by combined rosiglitazone and clomiphene citrate therapy.
    Shobokshi A; Shaarawy M
    J Soc Gynecol Investig; 2003 Feb; 10(2):99-104. PubMed ID: 12593999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome.
    Morin-Papunen LC; Koivunen RM; Ruokonen A; Martikainen HK
    Fertil Steril; 1998 Apr; 69(4):691-6. PubMed ID: 9548159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovulation induction in polycystic ovary syndrome: Current options.
    Legro RS
    Best Pract Res Clin Obstet Gynaecol; 2016 Nov; 37():152-159. PubMed ID: 27866938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polycystic ovarian syndrome management options.
    Bates GW; Propst AM
    Obstet Gynecol Clin North Am; 2012 Dec; 39(4):495-506. PubMed ID: 23182556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of metformin on clinical, metabolic and endocrine outcomes in women with polycystic ovary syndrome: a meta-analysis of randomized controlled trials.
    Patel R; Shah G
    Curr Med Res Opin; 2017 Sep; 33(9):1545-1557. PubMed ID: 28058854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased insulin-like growth factor-I levels in women with polycystic ovary syndrome, and beneficial effects of metformin therapy.
    Berker B; Emral R; Demirel C; Corapcioglu D; Unlu C; Kose K
    Gynecol Endocrinol; 2004 Sep; 19(3):125-33. PubMed ID: 15697073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.